While there has been plenty of attention in recent months on the rollout of legal access to psychedelics—in Oregon, Colorado, and beyond—what often gets lost in the hype is just how much psychedelic use is growing across the globe, independent of these stories.
Beyond the currently legal avenues of ketamine therapy, psilocybin services in Oregon, and clinical trials, more and more people are also seeking international retreats, underground guides, community ceremonies, and mail-order mushrooms. Not everyone who uses psychedelics in these contexts will require professional support, but many will—and almost all will benefit from a workforce of health professionals who are educated about the risks and benefits of psychedelic use–whether it be their therapist, social worker, or family doctor.
In this month’s installment of Fluence’s webinar series, join Psychologist and Co-Founder Ingmar Gorman, Fluence’s Director of the Psychedelic Harm Reduction and Integration Program Dr. Alex Camargo, and LCSW and integration therapist Amy Johnson for a discussion on the opportunities and challenges of doing this kind of work right now as a clinician.
Webinar attendees will learn:
- What psychedelic harm reduction and integration is and how it differs from psychedelic-assisted therapy
- What it’s like to practice this modality as a clinician right now, including how this modality can create unique opportunities to expand your practice
- How Fluence’s curriculum supports this work, as well as practical information about where to start with certification
A Q&A period will follow.
This webinar was recorded live February 20, 2023 @ 3:00 PM – 4:00 PM EST